Home

Why Choose Medcrave Mission & Vision Partners & Supporters News & Press Release

Journals eBooks Videos Reprints

Magazines Editors-in-Chief FAQs Contact Us ☰

Inhibition of glycogen synthase Kinase-3B (GSK-3B) as a novel host-directed therapeutic strategy against erythrocytic stage malaria and cerebral pathogenesis

: Journal of Microbiology & Experimentation
: Mosab Nouraldein Mohammed Hamad

PDF Full Text

Keywords

Host-Directed Therapy; Platelet Factor 4; Malaria; Cerebral Malaria; Macrophage Polarization; PfGSK-3; Platelet Activation; Neuroinflammation; Drug Repurposing.

© 2014-2026 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials